ÂÜÀòÂÒÂ×

Eric joined Cyrus in March of 2022 as Vice President of Drug Discovery. He is a seasoned biotech drug hunter with over 20 years of experience in discovery research and translational drug development, assembling and leading multi-disciplinary, cross-functional teams to advance first-in-class therapeutic candidates into the clinic. He has achieved key development milestones in the fields of immuno-oncology, infectious disease, autoimmunity/inflammation, and neuroscience, taking multiple early-stage therapeutics through preclinical development and into early clinical studies.

Prior to Cyrus, Eric was a founding scientist and held leadership positions at Kineta Inc., most recently as Executive Vice President of Research and Development responsible for leading discovery, non-clinical, CMC, regulatory and clinical R&D operations. Before Kineta, he was a scientist at Illumigen Biosciences leading efforts in assay development, in vitro and in vivo pharmacology, and CMC process development. Eric is a co-inventor and co-author on numerous patents and publications related to drug discovery, therapeutics formulation and manufacturing, vaccinology, pharmacology, and clinical development. Eric received his B.S. and M.S. degrees in Medical Technology and Clinical Laboratory Sciences at Michigan State University and earned his PhD in Microbiology and Immunology from the Medical University of Ohio at Toledo.